homehome Home chatchat Notifications


New vaccine is incredibly efficient at preventing typhoid

Antibiotic-resistant typhoid is spreading in some parts of the world so this news comes in the nick of time.

Melvin Sanicas
December 5, 2019 @ 7:50 pm

share Share

Caused by the bacterium Salmonella Typhi, typhoid is a major cause of fever in children in low- and middle-income countries and is responsible for nearly 11 million cases and more than 116,000 deaths a year worldwide.

It is usually spread through contaminated food or water. Once Salmonella Typhi bacteria are eaten or drunk, they multiply and spread into the bloodstream. Symptoms include prolonged high fever, fatigue, headache, nausea, abdominal pain, and constipation or diarrhoea. Some patients may have a rash. Severe cases may lead to serious complications or even death. Salmonella Typhi lives only in humans.

In 2018, the World Health Organization (WHO) recommended the introduction of typhoid conjugate vaccine (TCV) for infants and children over six months of age in typhoid-endemic countries, and added it to its list of pre-qualified vaccines.

Prior to TCV, two vaccines have been used for many years to protect people from typhoid fever, an injectable vaccine based on the purified antigen for people aged over 2 years and a live attenuated oral vaccine in capsule formulation for people aged over 5 years. These vaccines do not provide long-lasting immunity and are not approved for children younger than 2 years old.

Although TCV has been shown to protect against the disease in studies involving healthy volunteers in the UK, no efficacy studies in endemic populations had been completed. Now, the Typhoid Vaccine Acceleration Consortium (TyVAC), which includes researchers from the University of Oxford, the University of Maryland School of Medicine, and PATH has completed a large field study in Nepal and published the interim analysis in the New England Journal of Medicine.

The study involved 20,000 children aged 9 months to 16 years of age, who were randomly given one of two vaccines: half received TCV and half received the Group A meningococcal (MenA) vaccine – the latter acted as the control group.

Blood tests showed that typhoid occurred in 7 participants who received TCV and 38 receiving Men A vaccine. The researchers noted that these were preliminary results, and that the study will continue to follow-up the participants for two years.

Dr. Andrew Pollard, Professor of Paediatric Infection and Immunity at Oxford University’s Department of Paediatrics, said: “This is the first study to show that a single dose of TCV is safe, immunogenic, and effective, which provides clear evidence that vaccination will help efforts to control this serious disease and is a strong endorsement of the WHO policy for vaccine implementation.”

“The efficacy of these results in an endemic population adds to a growing body of evidence supporting the use of TCV to reduce disease and save lives in populations that lack clean water and improved sanitation,” said Dr. Kathleen Neuzil, MD, MPH director of the Center for Vaccine Development and Global Health at the University of Maryland School of Medicine and director of TyVAC.

These results show the vaccine has the potential to significantly reduce the burden of typhoid in high-risk populations. This is especially timely with the recent spread of extensively drug-resistant typhoid, which threatens child health in affected regions.

Pakistan’s current typhoid outbreak is the first-ever reported outbreak of ceftriaxone-resistant typhoid and represents an alarming trend in the spread of drug-resistant typhoid. Not only is the strain resistant to ceftriaxone, the standard treatment in many parts of the world, but it is also resistant to most antibiotics commonly used for typhoid, making it increasingly challenging and costly to treat.

TCVs have the potential to overcome many of the challenges that impeded uptake of earlier vaccines, including longer-lasting protection, fewer doses, and suitability for children under two years of age, allowing for inclusion in routine childhood immunization programs.

share Share

Cats Came Bearing Gods: Religion and Trade Shaped the Rise of the Domestic Cat in Europe

Two groundbreaking studies challenge the old narrative that cats followed early farmers into Europe.

Tiny Chinese Satellite Sent Hack-Proof Quantum Messages 12,900 Kilometers Through Space. Is a Quantum Internet Around the Corner?

The US and Europe are now racing to catch up to China.

The People of Carthage Weren’t Who We Thought They Were

The Punic people had almost no genetic ties to Phoenicians, even though the latter founded the great city of Carthage.

RFK Jr loves raw milk. Now, he's suspending milk quality tests due to Trump cuts

Imagine pouring a glass of milk for your child and wondering if it’s safe.

A Roman gladiator died fighting a lion in England and his 1,800-year-old skeleton proves it

It's the first-ever evidence of man-lion combat found in the Roman period.

This Surprising Protein Shift Could Add Years to Your Life, Study Finds

A global study ties plant protein to longer adult lives, but early life needs differ.

Scientists Create a 'Power Bar' for Bees to Replace Pollen and Keep Colonies Alive Without Flowers

Researchers unveil a man-made “Power Bar” that could replace pollen for stressed honey bee colonies.

First-Ever Footage Captures a Living Colossal Squid—And It’s Just a Baby

A century after its discovery, the elusive giant finally reveals itself on camera.

Ancient tree rings reveal the hidden reason Rome’s grip on Britain failed

Three scorching summers in antiquity triggered revolt, invasion, and a turning point in British history.

Oxford Academics Used a Human Skull as a Wine Cup—Until 2015

It sounds like a scene from gothic fiction, but it’s real.